Freyr Regulatory Radio
En podcast av Freyr Solutions
29 Avsnitt
-
Season 5: Episode 5 – Reporting Adverse Events Under MoCRA
Publicerades: 2024-03-01 -
Season 5: Episode 4 – Safety in Focus – MoCRA Safety Substantiation
Publicerades: 2024-03-01 -
Season 5: Episode 3 – Mastering Product Listing: A Comprehensive Guide to MoCRA Requirements
Publicerades: 2024-03-01 -
Season 5: Episode 2 – Untangling the Responsibilities of MoCRA Agents and RPs
Publicerades: 2024-03-01 -
Season 5: Episode 1 – MoCRA Facility Registration: What You Need to Know?
Publicerades: 2024-03-01 -
Season 4: Episode 5 - Key Considerations for Comparative Quality Studies for the Proposed Biosimilar Product in EU
Publicerades: 2023-09-26 -
Season 4: Episode 4 - Challenges in CMC Development of Biologics/Biosimilars
Publicerades: 2023-09-19 -
Season 4: Episode 3 - CMC Requirements for Biologics/Biosimilars
Publicerades: 2023-09-12 -
Season 4: Episode 2 - ICH Guidelines for CMC Development of Biologics/Biosimilars
Publicerades: 2023-09-05 -
Season 4: Episode 1 - Introduction to Biologics/Biosimilars and Regulatory Pathways for Approval in the EU
Publicerades: 2023-08-29 -
Season 3: Episode 6 - Regulatory Lifecycle Management of Medicinal Products
Publicerades: 2023-02-28 -
Season 3: Episode 5 - Medicinal Products’ Intellectual Patenting
Publicerades: 2023-02-21 -
Season 3: Episode 4 - US FDA’s Facilitated Regulatory Pathway and Their Significance
Publicerades: 2023-02-14 -
Season 3: Episode 3 - Procedures for Medicinal Products’ Approval
Publicerades: 2023-02-07 -
Season 3: Episode 2 - GDUFA & PDUFA Guidelines
Publicerades: 2023-01-31 -
Season 3: Episode 1 - US Market Entry & Landscape In Regulatory Affairs
Publicerades: 2023-01-24 -
Season 2: Episode 6 - Pharma Advertising and Promotions: Canada
Publicerades: 2022-12-14 -
Season 2: Episode 5 - Pharma Advertising and Promotions: Mexico
Publicerades: 2022-12-07 -
Season 2: Episode 4 - Pharma Advertising and Promotions: United Kingdom
Publicerades: 2022-11-30 -
Season 2: Episode 3 - Pharma Advertising and Promotions: Lithuania
Publicerades: 2022-11-23
Freyr is a leading, niche, full-service global Regulatory Solutions, and Services Company supporting, Large, Medium, and Small size global Life sciences companies, (Pharmaceutical | Generics | Medical Device | Biotechnology | Biosimilar | Consumer Healthcare | Cosmetics | Food and Food Supplements | Chemicals) in their entire Regulatory value-chain; ranging from Regulatory Strategy, Intelligence, Dossiers, Submissions, etc. to Post- Approval / Legacy Product Maintenance, Labeling, Artwork Change Management, and other related functions.
